Skip to main content

Month: May 2022

Plusgrade to Acquire Points in an All Cash Transaction

All outstanding common shares of Points to be acquired for US$25.00 per share TORONTO, May 09, 2022 (GLOBE NEWSWIRE) — Points.com Inc. (TSX: PTS) (NASDAQ: PCOM) (“Points” or the “Company”), the global leader in powering loyalty commerce, is pleased to announce that it has entered into an arrangement agreement (the “Arrangement Agreement”) pursuant to which a wholly-owned subsidiary (the “Purchaser”) of Plusgrade Parent L.P. (“Plusgrade”), a leading ancillary revenue platform for the global travel industry, will acquire all of the issued and outstanding common shares of the Company for US$25.00 per common share in cash (equivalent to C$32.21 assuming a 1.2882 exchange rate as per the Bank of Canada May 6 noon rate) (the “Consideration”) by way of a statutory plan of arrangement under the Canada Business Corporations Act (the “Transaction”). The...

Continue reading

VSBLTY REPORTS 2021 EARNINGS

Philadelphia, PA, May 09, 2022 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) (Frankfurt 5VS) (“VSBLTY”), a leading software provider of security and retail analytics technology, today announced its revenue for 2021 was $1.6 million (USD), which is a 164 percent increase over the previous year of $607K. VSBLTY technology provides enhanced customer engagement and audience measurement using machine learning and computer vision. Its industry leading VisionCaptor™ and DataCaptor™ software combine motion graphics and interactive brand messaging with cutting-edge computer vision measurement and insights. VSBLTY’s AI driven software Vector™ provides enhanced facial recognition that is crucial to strengthening today’s security requirements when recognizing weapons or suspicious persons in a crowd. The...

Continue reading

Recreational Vehicle Market Size to Hit USD 87.89 Billion by 2028 | Industry Share, Growth and Trends Analysis Report

According to Fortune Business Insights, the global Recreational Vehicle market size is projected to grow from USD 55.90 billion in 2021 to USD 87.89 billion in 2028, at CAGR of 6.7% during forecast period; Strong Demand for Comfortable Travel & Accommodation to Foster Industry Development Pune, India, May 09, 2022 (GLOBE NEWSWIRE) — The recreational vehicle market size was valued at USD 55.28 billion in 2020. The market is estimated to grow from USD 55.90 billion in 2021 to USD 87.89 billion in 2028, exhibiting a CAGR of 6.7% during the forecast period. Rising active campers and robust demand for comfortable travel & accommodation are expected to foster market development. Fortune Business Insights™ presents this information in its report titled “Recreational Vehicle Market, 2021-2028.” Recreational vehicles are automobiles...

Continue reading

High Voltage Cables Market Size [2021-2026] to Hit USD 54.97 Billion | Industry Trends, Growth, Share and Forecast Analysis

Surge in Need to Replace Old Grid Infrastructures with New Ones to Aid in Expansion of Global High Voltage Cables MarketHigh Voltage Cables Market Size Global High Voltage Cables Market SizePune, India, May 09, 2022 (GLOBE NEWSWIRE) — The global high voltage cables market size is projected to grow from USD 31.89 billion in 2018 to USD 54.97 billion in 2026, at CAGR of 7.11% during forecast period; Rapid urbanization witnessed worldwide to boost global high voltage cables market growth. On the basis of installation, the overhead installation segment is dominating the market because of the low transmission losses and easy installation processes. The report is based on an in-depth analysis of the high voltage cables market. It offers details about major factors propelling and repelling growth, along with major high voltage cables...

Continue reading

Vaxxinity Reports First Quarter 2022 Financial Results and Provides Corporate Updates

DALLAS, May 09, 2022 (GLOBE NEWSWIRE) — Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, today reported financial results for the first quarter ended March 31, 2022. “Vaxxinity has laid the groundwork to have multiple shots on goal this year after a productive and exciting start to 2022. The FDA granted Fast Track designation to our Alzheimer’s vaccine candidate and we completed enrollment for our Parkinson’s vaccine candidate with initial data expected in the second half of this year. We also initiated enrollment in our global pivotal Phase 3 trial of UB-612 for prevention of COVID-19 with the support of a CEPI grant,” said Mei Mei Hu, CEO of Vaxxinity. “As we pursue our mission to democratize health and bring transformative medicines to all patients in need,...

Continue reading

Adaptimmune Reports First Quarter Financial Results and Business Update

– Pooled data from Cohort 1 of the SPEARHEAD-1 trial and the Phase 1 trial of afami-cel in patients with sarcoma to be presented as a poster at ASCO – – Preclinical data for two novel next-generation T-cell therapies to be presented in two posters at ASGCT – – Updated MAGE-A4 expression levels from the Company’s screening protocol presented at AACR confirm the potential of this target in a broad range of solid tumors – – Appointed Jo Brewer as Chief Scientific Officer – – Financial guidance confirmed: funded into early 2024 – – Conference call to be held today at 8:00 a.m. EDT (1:00 p.m. BST) – PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 09, 2022 (GLOBE NEWSWIRE) — Adaptimmune Therapeutics plc (Nasdaq: ADAP), a leader in cell therapy to treat cancer,...

Continue reading

Genenta Appoints Industry Veteran Tim Obara as Head of Business Development

Extensive experience in business development with AstraZeneca and GSK MILAN, Italy and NEW YORK, May 09, 2022 (GLOBE NEWSWIRE) — Genenta Science (NASDAQ: GNTA), a clinical-stage biotechnology company pioneering the development of hematopoietic stem progenitor cell immuno-gene therapy for cancer, announces the appointment of Tim Obara, a highly experienced commercial healthcare executive, as Vice President Business Development. Tim has significant experience across a broad range of therapeutic areas and with global responsibility. He joins Genenta from the University of Pennsylvania Gene Therapy Program, where he was Executive Director of Research Operations. He has previously worked in senior business development roles at Amicus Therapeutics, AstraZeneca, GSK and the Singapore-based Tessa Therapeutics. Pierluigi Paracchi, CEO at...

Continue reading

Ayr Wellness to Hold First Quarter 2022 Conference Call on May 26, 2022 at 8:30 a.m. ET

MIAMI, May 09, 2022 (GLOBE NEWSWIRE) — Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (MSO), will hold a conference call on Thursday, May 26, 2022 at 8:30 a.m. ET to discuss its results for the first quarter ended March 31, 2022. Ayr CEO Jonathan Sandelman, Co-COO Jennifer Drake and CFO Brad Asher will host the conference call, followed by a question-and-answer period. The Company will provide its financial results in a press release prior to the call. Date: Thursday, May 26, 2022Time: 8:30 a.m. ETToll-free dial-in number: (800) 319-4610International dial-in number: (604) 638-5340Conference ID: 10018928Webcast: https://www.gowebcasting.com/11803 A telephonic replay of the conference call will also be available for one month beginning at 11:30...

Continue reading

Colliers adds building consultancy and project management leader in the United Kingdom

Brings scale and additional capabilities to accelerate growth TORONTO and LONDON, May 09, 2022 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management company, Colliers (NASDAQ and TSX: CIGI), announced today it has acquired a majority interest in Paragon Building Consultancy Holdings Limited (“Paragon”), one of the UK’s top independent building consultancy and project management firms. Paragon will be combined with Colliers’ existing project management business bringing scale and additional capabilities in the UK and Europe. Paragon’s senior management team will lead the combined operations and retain significant equity going forward under Colliers’ unique partnership model. Financial terms were not disclosed. Founded in London in 2009, Paragon’s 150 professionals from the firm’s six UK offices provide...

Continue reading

Tyson Foods Reports Second Quarter 2022 Results

Improving Operational Execution and Strong Consumer Demand Drive Operating Results SPRINGDALE, Ark., May 09, 2022 (GLOBE NEWSWIRE) — Tyson Foods, Inc. (NYSE: TSN), one of the world’s largest food companies and a recognized leader in protein with leading brands including Tyson, Jimmy Dean, Hillshire Farm, Ball Park, Wright, Aidells, ibp and State Fair, today reported the following results:(in millions, except per share data) Second Quarter   Six Months Ended    2022       2021       2022       2021  Sales $ 13,117     $ 11,300     $ 26,050     $ 21,760  Operating Income   1,156       720       2,611       1,425                 Net Income   833       477       1,959       949  Less: Net Income Attributable to Noncontrolling Interests   4       1       9       6  Net Income Attributable to Tyson $ 829     $ 476     $ 1,950     $ 943                 Net...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.